Solara Active Pharma Sci Share Price

Solara Active Pharma Sciences Limited is an India-based global, pureplay active pharmaceutical ingredients (API) company. The Company is engaged in the manufacturing and development of APIs and offers contract manufacturing and development services for global companies. Its commercial product category includes Albendazole, Aprepitant (Antiemetic), Colchicine, Citicoline Sodium, Disulfiram, Dolutegravir, Etomidate, Flucytosine, Ibuprofen Arginine, Lurasidone Hydrochloride, Rifaximin, Tioconazole, Zileuton and others. Its research and development (R&D) product category includes Brivaracetam, Flecainide Acetate, Naproxen Base, Obeticholic acid, Patiromer Sorbitex Calcium, Rotigotine, Safinamide, Sapropterin, Sugammadex, Tranexamic Acid, Sucroferric Oxyhydroxide and others. Its business is spread across 70 countries with operations in the key markets of North America, Europe, Japan, South Korea and the Middle East and North Africa. It has one R&D center in Chennai. As of 14 Jun 2026, Solara Active Pharma Sci share price is ₹608.55. The stock opened at ₹581.05, compared to its previous close of ₹580.70. During today's trading session, Solara Active Pharma Sci share price moved in the range of ₹581.05 to ₹619.90, with an average price of ₹600.47 for the day. Looking at its last 52-week, the stock has touched a low of ₹581.05 and a high of ₹619.90. On the performance front, Solara Active Pharma Sci share price has increased by 3.06% over the last six months and is up 19.57% on a year-on-year basis.

The market capitalization of Solara Active Pharma Sci is ₹2,900 Crs, with a P/E ratio of -392.2 and a dividend yield of 0.00%.